arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

SHOULDER INNOVATIONS, INC.

SI
$17.36 ▼ -0.31 (-1.75%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
3 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Bearish
auto_awesome

Analytical Summary

SHOULDER INNOVATIONS, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $150.6M
Dividend Yield —
Revenue Growth 49.6%
Op. Margin -55.6% ↘
ROIC -16.9% ↘
FCF / Share $-4.15
Trailing P/E —
Price / Book 2.5x
FCF Yield —
Debt / Equity 0.11
info Valuation on last close. End-of-day price, Sep 23, 2026.

3-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$47.32M
↑ +49.6% —
Net Income Profit after all expenses
$-40.36M
↓ -158.4% —
Operating Margin Operating profit as % of sales
-55.6%
↓ -19.9% 5th
Long-Term Debt Long-term obligations
$14.91M
↑ +1.7% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
4
Returns
24
Financial Health ↓
54
Cash Quality ↓
60

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 3 years · 11 quarters